PREVDUO

Serial Number 97698414
Registration 7178136
700

Registration Progress

Application Filed
Nov 30, 2022
Under Examination
Apr 11, 2023
Approved for Publication
Feb 14, 2023
Published for Opposition
Feb 14, 2023
Registered
Sep 26, 2023

Trademark Image

PREVDUO

Basic Information

Serial Number
97698414
Registration Number
7178136
Filing Date
November 30, 2022
Registration Date
September 26, 2023
Published for Opposition
February 14, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Sep 26, 2023
Registration
Registered
Classes
005

Rights Holder

AZURITY PHARMACEUTICALS, INC.

03
Address
8 CABOT ROAD
SUITE 2000
WOBURN, MA 01801

Ownership History

Slayback Pharma Limited Liability Company

Original Applicant
16
Princeton, NJ

Slayback Pharma Limited Liability Company

Owner at Publication
16
Princeton, NJ

Slayback Pharma Limited Liability Company

Original Registrant
16
Princeton, NJ

AZURITY PHARMACEUTICALS, INC.

New Owner After Registration #1
03
WOBURN, MA

Legal Representation

Attorney
Douglas R. Wolf

USPTO Deadlines

Next Deadline
1374 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20230926)
Due Date
September 26, 2029
Grace Period Ends
March 26, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

23 events
Date Code Type Description Documents
Mar 19, 2025 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Mar 5, 2025 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Jul 16, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jul 16, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jul 16, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jul 16, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jul 16, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Sep 26, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Sep 26, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 19, 2023 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Aug 18, 2023 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Aug 10, 2023 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jul 31, 2023 IUAF S USE AMENDMENT FILED Loading...
Aug 10, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jul 31, 2023 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Apr 11, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 14, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 14, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 25, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 9, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 5, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 27, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 3, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Medicines and pharmaceutical preparations for human use, namely, anticholinergics, antimuscarinics, cholinesterase inhibitors, combination of antimuscarinic agent and cholinesterase inhibitor, muscle relaxants, muscle relaxant antagonists, anesthetic preparations, neuromuscular blocking agents, combination products to reverse neuromuscular blockade; Medicines and pharmaceutical preparations for the reversal of the effects of non-depolarizing neuromuscular blocking agents, while minimizing the peripheral muscarinic effects
First Use Anywhere: Jun 12, 2023
First Use in Commerce: Jun 12, 2023

Classification

International Classes
005